[Correlation between C-MYC protein expression and genetic abnormalities in diffuse large B-cell lymphoma].

Area of Science:

• Oncology
• Molecular Biology
• Hematopathology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
• The oncogene C-MYC plays a critical role in lymphomagenesis.
• Understanding the correlation between C-MYC protein expression and gene abnormalities is crucial for DLBCL diagnosis and prognosis.

Purpose of the Study:

• To investigate the relationship between C-MYC protein expression and C-MYC gene abnormalities in DLBCL.
• To determine if C-MYC protein levels can predict C-MYC gene alterations.

Main Methods:

• Immunohistochemistry was used to detect C-MYC protein expression in 42 DLBCL cases.
• Fluorescence in situ hybridization (FISH) was employed to identify C-MYC gene abnormalities, including translocation and amplification.
• Correlation analysis was performed to assess the relationship between protein expression and gene status.

Main Results:

• C-MYC protein expression was positive in 47.6% of DLBCL cases.
• C-MYC gene abnormalities were detected in 26.2% of cases, primarily C-MYC gene translocation (23.8%).
• A significant association was found between high C-MYC protein expression and C-MYC gene translocation (P=0.001).

Conclusions:

• High C-MYC protein expression (≥40%) is closely linked to C-MYC gene translocation in DLBCL.
• C-MYC protein detection may serve as a valuable surrogate marker for C-MYC gene translocation.
• This finding aids in understanding DLBCL pathogenesis and may inform diagnostic strategies.